Perfect Medical Health Management Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Perfect Medical Health Management wird ein jährliches Gewinn- und Umsatzwachstum von 16.6% bzw. 5.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 16.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 86.9% betragen.

Wichtige Informationen

16.6%

Wachstumsrate der Gewinne

16.3%

EPS-Wachstumsrate

Consumer Services Gewinnwachstum	20.2%
Wachstumsrate der Einnahmen	5.7%
Zukünftige Eigenkapitalrendite	86.9%
Analystenabdeckung	Low
Zuletzt aktualisiert	03 Dec 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Perfect Medical Health Management Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 19

Recent updates

At HK$2.27, Is Perfect Medical Health Management Limited (HKG:1830) Worth Looking At Closely?

Aug 18

This Analyst Just Downgraded Their Perfect Medical Health Management Limited (HKG:1830) EPS Forecasts

Jul 22

Perfect Medical Health Management Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 19

Sentiment Still Eluding Perfect Medical Health Management Limited (HKG:1830)

Apr 15

Perfect Medical Health Management's (HKG:1830) Dividend Will Be HK$0.142

Nov 27

Perfect Medical Health Management's (HKG:1830) Upcoming Dividend Will Be Larger Than Last Year's

Jul 11

Is Now An Opportune Moment To Examine Perfect Medical Health Management Limited (HKG:1830)?

Jun 29

Perfect Medical Health Management (HKG:1830) Is Reinvesting To Multiply In Value

May 31

Perfect Medical Health Management's (HKG:1830) Shareholders Will Receive A Smaller Dividend Than Last Year

Nov 27

Should You Investigate Perfect Medical Health Management Limited (HKG:1830) At HK$3.07?

Nov 08

Bullish: This Analyst Just Lifted Their Perfect Medical Health Management Limited (HKG:1830) Outlook For This Year

Aug 14

Perfect Medical Health Management's (HKG:1830) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 14

Is Now An Opportune Moment To Examine Perfect Medical Health Management Limited (HKG:1830)?

May 10

Perfect Medical Health Management's (HKG:1830) Upcoming Dividend Will Be Larger Than Last Year's

Dec 01

Investors Shouldn't Overlook The Favourable Returns On Capital At Perfect Medical Health Management (HKG:1830)

Nov 01

Perfect Medical Health Management (HKG:1830) Is Paying Out Less In Dividends Than Last Year

Aug 17

Investors Shouldn't Overlook The Favourable Returns On Capital At Perfect Medical Health Management (HKG:1830)

Jul 25

Perfect Medical Health Management (HKG:1830) Will Pay A Smaller Dividend Than Last Year

Jul 03

Estimating The Intrinsic Value Of Perfect Medical Health Management Limited (HKG:1830)

Jun 28

A Look Into Perfect Shape Medical's (HKG:1830) Impressive Returns On Capital

Apr 12

Is Perfect Shape Medical Limited's (HKG:1830) 6.8% Dividend Worth Your Time?

Mar 10

Trade Alert: The Founder Of Perfect Shape Medical Limited (HKG:1830), Kong Au-Yeung, Has Just Spent HK$11m Buying A Few More Shares

Feb 23

What You Need To Know About Perfect Shape Medical Limited's (HKG:1830) Investor Composition

Feb 21

Is Perfect Shape Medical Limited's (HKG:1830) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 06

Gewinn- und Umsatzwachstumsprognosen

SEHK:1830 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (HKD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	1,463	440	437	457	1
3/31/2026	1,405	380	389	408	1
3/31/2025	1,275	323	361	379	1
9/30/2024	1,295	290	358	412	N/A
6/30/2024	1,344	303	401	455	N/A
3/31/2024	1,393	316	443	497	N/A
12/31/2023	1,416	324	483	523	N/A
9/30/2023	1,439	331	523	550	N/A
6/30/2023	1,414	324	528	555	N/A
3/31/2023	1,389	316	534	561	N/A
12/31/2022	1,303	278	421	507	N/A
9/30/2022	1,217	239	309	453	N/A
6/30/2022	1,283	272	339	484	N/A
3/31/2022	1,350	305	369	514	N/A
12/31/2021	1,366	335	453	565	N/A
9/30/2021	1,382	365	537	616	N/A
6/30/2021	1,236	325	529	607	N/A
3/31/2021	1,090	285	520	598	N/A
12/31/2020	1,066	269	511	598	N/A
9/30/2020	1,043	253	502	599	N/A
6/30/2020	1,142	307	525	621	N/A
3/31/2020	1,241	360	548	644	N/A
12/31/2019	1,278	381	555	630	N/A
9/30/2019	1,315	402	563	616	N/A
6/30/2019	1,256	360	481	535	N/A
3/31/2019	1,197	319	400	453	N/A
12/31/2018	1,141	296	343	389	N/A
9/30/2018	1,084	272	286	324	N/A
6/30/2018	995	233	N/A	284	N/A
3/31/2018	906	194	N/A	244	N/A
12/31/2017	850	165	N/A	247	N/A
9/30/2017	793	135	N/A	251	N/A
6/30/2017	775	113	N/A	228	N/A
3/31/2017	757	91	N/A	205	N/A
12/31/2016	778	92	N/A	190	N/A
9/30/2016	798	93	N/A	174	N/A
6/30/2016	839	112	N/A	183	N/A
3/31/2016	879	130	N/A	192	N/A
12/31/2015	870	134	N/A	226	N/A
9/30/2015	861	139	N/A	260	N/A
6/30/2015	795	137	N/A	254	N/A
3/31/2015	729	135	N/A	247	N/A
12/31/2014	645	123	N/A	200	N/A
9/30/2014	562	112	N/A	154	N/A
6/30/2014	516	98	N/A	122	N/A
3/31/2014	470	83	N/A	91	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 1830Das prognostizierte Gewinnwachstum (16.6% pro Jahr) liegt über der Sparquote (2.3%).

Ertrag vs. Markt: 1830Die Erträge des Unternehmens (16.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (11.3% pro Jahr).

Hohe Wachstumserträge: 1830Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 1830Die Einnahmen des Unternehmens (5.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.7% pro Jahr).

Hohe Wachstumseinnahmen: 1830Die Einnahmen des Unternehmens (5.7% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 1830Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (86.9%).

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2025/01/30 03:28
Aktienkurs zum Tagesende	2025/01/28 00:00
Gewinne	2024/09/30
Jährliche Einnahmen	2024/03/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

^* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie hier mehr.

Analysemodell und Schneeflocke

Einzelheiten zum Analysemodell, das zur Erstellung dieses Berichts verwendet wurde, finden Sie auf unserer Github-Seite. Wir haben auch Anleitungen zur Verwendung unserer Berichte und Tutorials auf Youtube.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf .

Analysten-Quellen

Perfect Medical Health Management Limited wird von 4 Analysten beobachtet. 1 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
Kam Wai Kwok	CGS International
Trung Tran	CGS International
null null	Core Pacific -Yamaichi International (H.K.) Limited

Perfect Medical Health Management Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus revenue estimates fall by 13%

Perfect Medical Health Management Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Consensus EPS estimates fall by 12%

Perfect Medical Health Management Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022

Price target increased to HK$8.40

Recent updates

First half dividend reduced to HK$0.11

First half 2025 earnings released: EPS: HK$0.11 (vs HK$0.13 in 1H 2024)

Perfect Medical Health Management Limited Announces Interim Dividend or the Six Months Ended 30 September 2024, Payable on 31 December 2024

Perfect Medical Health Management Limited Declares Special Dividend for the Six Months Ended 30 September 2024, Payable on 31 December 2024

Perfect Medical Health Management Limited to Report First Half, 2025 Results on Nov 29, 2024

Investor sentiment improves as stock rises 19%

At HK$2.27, Is Perfect Medical Health Management Limited (HKG:1830) Worth Looking At Closely?

Upcoming dividend of HK$0.17 per share

Consensus revenue estimates fall by 13%

This Analyst Just Downgraded Their Perfect Medical Health Management Limited (HKG:1830) EPS Forecasts

Perfect Medical Health Management Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Final dividend of HK$0.17 announced

Perfect Medical Health Management Limited, Annual General Meeting, Aug 09, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Perfect Medical Health Management Limited Proposes Special Dividend for the Year Ended 31 March 2024, Payable on 06 September 2024

New minor risk - Financial data availability

Perfect Medical Health Management Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 19%

Sentiment Still Eluding Perfect Medical Health Management Limited (HKG:1830)

Consensus EPS estimates fall by 12%

Upcoming dividend of HK$0.14 per share at 7.4% yield

Perfect Medical Health Management's (HKG:1830) Dividend Will Be HK$0.142

First half 2024 earnings released: EPS: HK$0.13 (vs HK$0.12 in 1H 2023)

Perfect Medical Health Management Limited Announces Payment of Special Dividend for the Six Months Ended 30 September 2023, Payable on 29 December 2023

Perfect Medical Health Management Limited to Report First Half, 2024 Results on Nov 24, 2023

Upcoming dividend of HK$0.17 per share at 5.8% yield

Now 21% undervalued

Perfect Medical Health Management Limited, Annual General Meeting, Aug 11, 2023

Perfect Medical Health Management's (HKG:1830) Upcoming Dividend Will Be Larger Than Last Year's

Perfect Medical Health Management Limited, Annual General Meeting, Aug 11, 2023

Founder recently bought HK$2.9m worth of stock

Is Now An Opportune Moment To Examine Perfect Medical Health Management Limited (HKG:1830)?

Perfect Medical Health Management Limited Proposes Special Dividend for the Year Ended 31 March 2023, Payable on 08 September 2023

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Perfect Medical Health Management Limited to Report Fiscal Year 2023 Results on Jun 28, 2023

Perfect Medical Health Management (HKG:1830) Is Reinvesting To Multiply In Value

Founder recently bought HK$1.0m worth of stock

Investor sentiment improved over the past week

Upcoming dividend of HK$0.13 per share

Perfect Medical Health Management's (HKG:1830) Shareholders Will Receive A Smaller Dividend Than Last Year

First half 2023 earnings released: EPS: HK$0.12 (vs HK$0.18 in 1H 2022)

Perfect Medical Health Management Limited Recommends Payment of an Interim Dividend for the Six Months Ended 30 September 2022, Payable on or Around 30 December 2022

Insufficient new directors

Perfect Medical Health Management Limited Provides Earnings Guidance for the Six Months Ended 30 September 2022

Perfect Medical Health Management Limited to Report First Half, 2023 Results on Nov 23, 2022

Should You Investigate Perfect Medical Health Management Limited (HKG:1830) At HK$3.07?

Founder recently bought HK$907k worth of stock

Investor sentiment deteriorated over the past week

Perfect Medical Health Management Limited Appoints So Hin Lung as Executive Director, Member of Each of the Nomination Committee and the Remuneration Committee

Founder exercised options to buy HK$5.0m worth of stock.

Perfect Medical Health Management Limited Announces Final Dividend for the Year Ended 31 March 2022, Payable on 30 September 2022

Bullish: This Analyst Just Lifted Their Perfect Medical Health Management Limited (HKG:1830) Outlook For This Year

Upcoming dividend of HK$0.071 per share

COO & Executive Director exercised options to buy HK$4.7m worth of stock.

Perfect Medical Health Management's (HKG:1830) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Perfect Medical Health Management Limited, Annual General Meeting, Aug 12, 2022

Perfect Medical Health Management Limited to Report Fiscal Year 2022 Results on Jun 30, 2022

Is Now An Opportune Moment To Examine Perfect Medical Health Management Limited (HKG:1830)?

Price target increased to HK$8.40

Insufficient new directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of HK$0.18 per share

Founder recently bought HK$6.1m worth of stock

Perfect Medical Health Management's (HKG:1830) Upcoming Dividend Will Be Larger Than Last Year's

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investors Shouldn't Overlook The Favourable Returns On Capital At Perfect Medical Health Management (HKG:1830)

Founder recently bought HK$5.8m worth of stock